Clinical Trial: Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Phase 2 Study of Topical AS101 for the Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women

Brief Summary: The primary objective of this study is to assess the safety and efficacy of topical AS101 as treatment for Female Androgenetic Alopecia (FAGA) in menopause women.

Detailed Summary:
Sponsor: Rabin Medical Center

Current Primary Outcome: hair density

Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Hair diameter, anagen/telogen ratio and hair growth rate,Global photographic assessment according to Female-Ludwig scale,
  • Self-administered satisfaction questionnaire


Original Secondary Outcome: Same as current

Information By: Rabin Medical Center

Dates:
Date Received: January 2, 2007
Date Started:
Date Completion:
Last Updated: January 3, 2007
Last Verified: December 2006